CytoDyn, Inc. (PINK SHEETS: CYDY) has completed analysis of its prospective, placebo-controlled study that used mice to compare nine variations of experimental DNA vaccines for the bird...
SANTA FE, N.M. & WORCESTER, Mass.--(BUSINESS WIRE)--CytoDyn, Inc. (Pink Sheets:CYDY) has appointed Shan Lu, MD, PhD, to its
Scientific Advisory Board. Dr. Lu, who is a Professor of Medicine...
SANTA FE, N.M.--(BUSINESS WIRE)--Because of a medical emergency and other unforeseen circumstances,
CytoDyn, Inc. (Pink Sheets:CYDY) was late filing a 10-QSB for the first
time. The...
NEW YORK--(BUSINESS WIRE)--CytoDyn, Inc. (OTCBB:CYDY) announced today that optimization of the
Company’s DNA-based pre-vaccines for influenza
(the flu) will be reported in an...
SANTA FE, N.M.--(BUSINESS WIRE)--CytoDyn, Inc. (OTCBB:CYDY), an emerging growth biotechnology company,
has placed a short movie clip (4.8 MB) on its web site at www.cytodyn.com.
The...
SANTA FE, N.M.--(BUSINESS WIRE)--Dorothy H. Bray, Ph.D., will chair the Scientific Advisory Board at
CytoDyn, Inc. (OTCBB:CYDY), the Company announced today. Dr. Bray has
garnered...
SANTA FE, N.M.--(BUSINESS WIRE)--Sept. 20, 2006--Prominent clinician and immunologist Robert H. Keller, M.D., M.C., FACP, AAHIVS has joined the Scientific Advisory Board of CytoDyn, Inc....
SANTA FE, N.M.--(BUSINESS WIRE)--Sept. 8, 2006--CytoDyn, Inc. (OTCBB:CYDY) is forming a separate Product Development Team to expedite development of its licensed DNA Influenza Pre-Vaccines by its...
TORONTO--(BUSINESS WIRE)--Aug. 17, 2006--At the suggestion of CytoDyn, Inc. (OTCBB:CYDY), Joe Trujillo, a senior field representative for U.S. Senator Pete Domenici (R-NM), spent a portion of his...
SANTA FE, N.M.--(BUSINESS WIRE)--Aug. 4, 2006--CytoDyn, Inc. (OTCBB:CYDY) has been invited to present clinical results from Cytolin(R) at the Treatment Horizons Forum of The AIDS Institute to be...
SANTA FE, N.M.--(BUSINESS WIRE)--July 27, 2006--CytoDyn, Inc. (OTCBB:CYDY) has briefed its shareholders on flu vaccines that compete with the DNA plasmids being developed by the company's wholly...
#2: CYDY News CytoDyn Acquires Advanced Influenza Technologies, Inc. from UTEK Corporation; Acquisition Includes License to DNA-Based Influenza Vaccine
SANTA FE, N.M. & TAMPA, Fla.--(BUSINESS WIRE)--July 21, 2006--CytoDyn, Inc. (OTCBB:CYDY), a development stage biotechnology company, and UTEK Corporation (AMEX:UTK) (LSE-AIM:UTK), a specialty...
SANTA FE, N.M.--(BUSINESS WIRE)--July 19, 2006--CytoDyn, Inc. (OTCBB:CYDY) has licensed an extensive portfolio of patents and entered into certain sponsored research agreements to add DNA plasmids...
